CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
postbioticsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07278024
NCT07278024N/ACompleted

To Investigate the Effect of Postbiotic Intervention on Vaginal Microbiota in Infertile Women

Kaohsiung Veterans General Hospital.·interventional·Posted Dec 11, 2025·Updated Dec 11, 2025

In Brief

A clinical study evaluating postbiotics for Infertile Women Undergoing IVF or ICSI. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This study investigates the effects of postbiotic intervention on vaginal microbiota in infertile patients. Using a pre-post test design, we will enroll 15 women aged 30-45 years with at least two IVF failures. Participants will receive postbiotic intervention for 8 weeks. Vaginal secretion samples will be collected before and after treatment for 16S rRNA sequencing analysis to assess microbial composition, dominant species distribution, α-diversity index, and Lactobacillus content. Primary outcomes include changes in vaginal microbiota composition and diversity, alterations in Lactobacillus abundance, and pregnancy rates in subsequent IVF-FET cycles.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedDec 11, 2025
Enrollment StartApr 1, 2025
Primary CompletionJul 31, 2025
Study CompletionNov 30, 2025
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7 months ago

Interventions

postbioticsother

Participants will self-administer postbiotic intervention via intravaginal suppositories containing purified bacteriocin peptides . The intervention consists of one suppository administered intravaginally at bedtime, once daily for 8 consecutive weeks (56 days total). Each suppository contains a standardized concentration of bacteriocins extracted from Lactobacillus strains.